Glaukos Corporation (GKOS), headquartered in San Clemente, California, is a leading innovator in ophthalmic medical technology and pharmaceuticals, dedicated to developing cutting-edge treatments for glaucoma, corneal disorders, and retinal diseases. The company is renowned for its expertise in minimally invasive surgical techniques and advanced drug delivery systems, which have substantially enhanced patient outcomes and quality of life. With a strong focus on research and development, Glaukos is strategically positioned to meet the rising demand for effective ophthalmic therapies, reinforcing its role as a key player in the industry and in the global fight against blindness and vision impairment.